Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CSPC Pharmaceutical Group ( (HK:1093) ) just unveiled an announcement.
CSPC Pharmaceutical Group Limited has proposed a final ordinary dividend of HKD 0.15 per share for the financial year ended 31 December 2025, underscoring its continued commitment to returning cash to shareholders. The payout, subject to shareholder approval on 28 May 2026, reflects the company’s confidence in its financial position and cash generation.
The shares will trade ex-dividend on 24 June 2026, with the record date set for 29 June 2026 and payment scheduled for 15 July 2026 in Hong Kong dollars. The announcement provides clarity on the timetable and mechanics of the distribution, offering income visibility for investors and signaling ongoing stability in the group’s capital management strategy.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$10.70 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a Hong Kong-listed pharmaceutical company engaged in the research, development, manufacturing and sale of a broad range of pharmaceutical products. The group focuses on both innovative and generic medicines, serving hospital, prescription and over-the-counter markets in China and selected international markets.
Average Trading Volume: 110,368,095
Technical Sentiment Signal: Buy
Current Market Cap: HK$95.13B
Find detailed analytics on 1093 stock on TipRanks’ Stock Analysis page.